Alfred Huang
Family Medicine · Irving, TXNPI 1083689194
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 472 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by Amarin Pharma, Inc. at 27.5% of the total. Reporting peaked in 2021 at $2,551 and has fallen 81.2% since, to $480 in 2025. Among family medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 472 payments — averaging $18.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$2K
- AstraZeneca$1K
- Boehringer Ingelheim$1K
- Novo Nordisk$768
- Sanofi-aventis U.S. LLC$579
- Lilly USA, LLC$456
- plus $2K from 22 others
What the payments were for
- Food & beverage$8,725100%
- Education$370%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 122 | $2,410 |
| AstraZeneca | 66 | $1,231 |
| Boehringer Ingelheim | 48 | $1,085 |
| Novo Nordisk | 50 | $768 |
| Sanofi-aventis U.S. LLC | 30 | $579 |
| Lilly USA, LLC | 27 | $456 |
| AbbVie(2 entities) | 18 | $301 |
| Johnson & Johnson | 16 | $233 |
| Pfizer | 8 | $232 |
| Kowa Pharmaceuticals America, Inc. | 13 | $199 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $179 |
| Merck | 12 | $170 |
| Otsuka America Pharmaceutical, Inc. | 8 | $134 |
| Currax Pharmaceuticals LLC | 9 | $133 |
| Amgen | 6 | $101 |
| GSK | 4 | $93 |
| Bayer | 5 | $92 |
| Astellas Pharma US Inc | 5 | $88 |
| Arbor Pharmaceuticals, Inc. | 3 | $58 |
| Idorsia Pharmaceuticals US Inc | 2 | $48 |
| Dermira, Inc. | 2 | $40 |
| Lundbeck LLC | 2 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Abbott | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Boston Scientific | 1 | $14 |
| Vistapharm, Inc. | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vascepa$134
How this compares
$8,762 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 11 | $216 |
| Atorvastatin Calcium | 20 | $163 |
| Alprazolam | 13 | $74 |
| Clonazepam | 12 | $30 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Irving
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.